These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23647964)

  • 21. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model.
    Wang W; Jiang Q; Zhang H; Jin P; Yuan X; Wei Y; Hu S
    Regen Med; 2011 Mar; 6(2):179-90. PubMed ID: 21391852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
    Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.
    Zhang W; Liu XC; Yang L; Zhu DL; Zhang YD; Chen Y; Zhang HY
    Coron Artery Dis; 2013 Nov; 24(7):549-58. PubMed ID: 23892469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction.
    Du YY; Zhou SH; Zhou T; Su H; Pan HW; Du WH; Liu B; Liu QM
    Cytotherapy; 2008; 10(5):469-78. PubMed ID: 18608353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of mesenchymal stem cells exerts a greater long-term effect than bone marrow mononuclear cells in a chronic myocardial infarction model in rat.
    Mazo M; Gavira JJ; Abizanda G; Moreno C; Ecay M; Soriano M; Aranda P; Collantes M; Alegría E; Merino J; Peñuelas I; García Verdugo JM; Pelacho B; Prósper F
    Cell Transplant; 2010; 19(3):313-28. PubMed ID: 19919732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats.
    Hou M; Yang KM; Zhang H; Zhu WQ; Duan FJ; Wang H; Song YH; Wei YJ; Hu SS
    Int J Cardiol; 2007 Feb; 115(2):220-8. PubMed ID: 16889848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart.
    Fiumana E; Pasquinelli G; Foroni L; Carboni M; Bonafé F; Orrico C; Nardo B; Tsivian M; Neri F; Arpesella G; Guarnieri C; Caldarera CM; Muscari C
    J Surg Res; 2013 Jan; 179(1):e21-9. PubMed ID: 22475350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
    Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction.
    Huang F; Li ML; Fang ZF; Hu XQ; Liu QM; Liu ZJ; Tang L; Zhao YS; Zhou SH
    Cardiology; 2013; 125(1):18-30. PubMed ID: 23615185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal Stem Cell (MSC) Transplantation Accompanied by Activation of Invariant Natural Killer T Cells Further Ameliorates Post-infarct Cardiac Remodeling in Mice.
    Li W; Huang Y; Gao C; Zhu Z; Dai G
    Discov Med; 2021; 32(166):51-63. PubMed ID: 35219346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transplantation of SIRT1-engineered aged mesenchymal stem cells improves cardiac function in a rat myocardial infarction model.
    Liu X; Chen H; Zhu W; Chen H; Hu X; Jiang Z; Xu Y; Zhou Y; Wang K; Wang L; Chen P; Hu H; Wang C; Zhang N; Ma Q; Huang M; Hu D; Zhang L; Wu R; Wang Y; Xu Q; Yu H; Wang J
    J Heart Lung Transplant; 2014 Oct; 33(10):1083-92. PubMed ID: 25034794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mesenchymal stem cells implantation increases the myofibroblasts congregating in infarct region in a rat model of myocardial infarction].
    Du YY; Yao R; Pu S; Zhao XY; Liu GH; Zhao LS; Chen QH; Li L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1045-50. PubMed ID: 23363722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iron oxide nanoparticle-mediated development of cellular gap junction crosstalk to improve mesenchymal stem cells' therapeutic efficacy for myocardial infarction.
    Han J; Kim B; Shin JY; Ryu S; Noh M; Woo J; Park JS; Lee Y; Lee N; Hyeon T; Choi D; Kim BS
    ACS Nano; 2015 Mar; 9(3):2805-19. PubMed ID: 25688594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implanted bone marrow-derived mesenchymal stem cells fail to metabolically stabilize or recover electromechanical function in infarcted hearts.
    Eun LY; Song H; Choi E; Lee TG; Moon DW; Hwang D; Byun KH; Sul JH; Hwang KC
    Tissue Cell; 2011 Aug; 43(4):238-45. PubMed ID: 21700305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
    Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
    Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction.
    Glass C; Singla DK
    Cell Transplant; 2012; 21(9):1931-44. PubMed ID: 22449760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage subpopulations are essential for infarct repair with and without stem cell therapy.
    Ben-Mordechai T; Holbova R; Landa-Rouben N; Harel-Adar T; Feinberg MS; Abd Elrahman I; Blum G; Epstein FH; Silman Z; Cohen S; Leor J
    J Am Coll Cardiol; 2013 Nov; 62(20):1890-901. PubMed ID: 23973704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.
    Rahbarghazi R; Nassiri SM; Ahmadi SH; Mohammadi E; Rabbani S; Araghi A; Hosseinkhani H
    Int J Cardiol; 2014 May; 173(3):453-66. PubMed ID: 24679689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
    Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
    Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size.
    Boomsma RA; Swaminathan PD; Geenen DL
    Int J Cardiol; 2007 Oct; 122(1):17-28. PubMed ID: 17187879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.